Huiam Mubarak, MD

Lindsay Frerichs, MD, is a neurologist in the Lewis Headache Center and an assistant professor in the Department of Neurology at Barrow Neurological Institute. She is board certified in neurology by the American Board of Psychiatry and Neurology and in headache medicine by the United Council for Neurologic Subspecialties. Dr. Frerichs’ expertise includes diagnosing and treating migraine, cluster headache, intracranial hypotension, idiopathic intracranial hypertension, trigeminal neuralgia, and occipital neuralgia. In addition to managing headache disorders with medication, she is experienced in nerve block and Botox procedures. She is a member of the American Academy of Neurology, the American Headache Society, the Headache Cooperative of the Pacific, and the Southern Headache Society. Dr. Frerichs earned her medical degree from the University of Texas Health Science Center in San Antonio. She completed her neurology residency at Washington University in St. Louis, Missouri and a fellowship in headache medicine at University of Texas Southwestern in Dallas.

Brad A. Racette, MD, FAAN, is the Kemper and Ethel Marley Professor and Chair of Neurology at Barrow Neurological Institute. He is board certified in neurology by the American Board of Psychiatry and Neurology. Dr. Racette’s clinical expertise includes the diagnosis and management of all types of movement disorders, and he has a special expertise in the use of botulinum toxin for limb disorders. He is a fellow of the American Academy of Neurology and the American Neurological Association. He is the past chairman of the Neurological, Aging, and Musculoskeletal Epidemiology Study Section at the National Institutes of Health (NIH) and a current member of the National Advisory Environmental Health Sciences Council for the National Institute of Environmental Health Sciences. He has served as an advisor for numerous international regulatory agencies. He is an honorary professor of public health at the University of Witwatersrand in Johannesburg, South Africa, and a professor emeritus at Washington University. Dr. Racette earned his medical degree from the Feinberg School of Medicine at Northwestern University in Chicago and his bachelor’s degree in molecular biology from Princeton University in New Jersey. He completed his neurology residency and a fellowship in movement disorders at Washington University School of Medicine in St. Louis. He then joined the faculty at Washington University, where he held the roles of Robert Allan Finke professor of neurology and executive vice-chairman of neurology. Dr. Racette’s research focuses on manganese neurotoxicity, environmental risk factors for Parkinson’s disease, and administrative data studies of Parkinson’s disease and other neurologic diseases. He has authored over 160 peer-reviewed publications. He is supported by the NIH, Michael J. Fox Foundation, Department of Defense, Cure Alzheimer’s Fund, Northeast ALS Consortium, and American Parkinson Disease Association.

Ruchira Jha, MD, MSc, is the division chief of Neurocritical Care, medical director of the Neurointensive Care Unit, and a professor in the departments of Neurology, Neurosurgery, and Translational Neuroscience at Barrow Neurological Institute. She is a clinical neurointensivist. She is board certified in neurology by the American Board of Psychiatry and Neurology and in neurocritical care by the United Council for Neurologic Subspecialties. Dr. Jha’s expertise includes clinical and translational research in neurotrauma and neurocritical care. She is a member of the American Academy of Neurology, the American Neurological Association, the National Neurotrauma Society, the Neurocritical Care Society, the Society for Neuroscience, and the Society of Critical Care Medicine. Dr. Jha earned her medical degree from Harvard Medical School in Boston, Massachusetts. She also earned a Master of Science degree in clinical and translational research from the University of Pittsburgh in Pennsylvania. Dr. Jha completed her neurology residency, chief residency, and a fellowship in neurocritical care at Massachusetts General Hospital and Brigham & Women’s Hospital through the Harvard Medical School Partners Program. Dr. Jha has received prestigious awards from the National Institutes of Health (NIH) and other foundations to pursue her research. She uses a translational approach to evaluate and develop individualized targets against cerebral edema to improve outcomes after traumatic brain injury (TBI). She has multiple publications and national presentations in this field. She is also involved in collaborations with multicenter TBI consortia, such as TRACK TBI and GAIN (Genetic Associations in Neurotrauma), for her research. Dr. Jha serves on the editorial board of JAMA Neurology and is the critical care section editor for the journal Stroke.